Form 8-k (Q1-12)

0001122304-12-000075.txt : 20120426 0001122304-12-000075.hdr.sgml : 20120426 20120426063043 ACCESSION NUMBER: 0001122304-12-000075 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20120426 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120426 DATE AS OF CHANGE: 20120426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETNA INC /PA/ CENTRAL INDEX KEY: 0001122304 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 232229683 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16095 FILM NUMBER: 12781281 BUSINESS ADDRESS: STREET 1: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 BUSINESS PHONE: 8602730123 MAIL ADDRESS: STREET 1: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 FORMER COMPANY: FORMER CONFORMED NAME: AETNA U S HEALTHCARE INC DATE OF NAME CHANGE: 20000822 8-K 1 form8-k.htm FORM 8-K Form 8-k (Q1-12)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported):	April 26, 2012

Aetna Inc.

(Exact name of registrant as specified in its charter)



Pennsylvania	1-16095	23-2229683
(State or other jurisdiction of	(Commission	(IRS Employer
incorporation)	File Number)	Identification No.)



151 Farmington Avenue, Hartford, CT	06156
(Address of principal executive offices)	(Zip Code)



Registrant's telephone number, including area code:	(860) 273-0123



Former name or former address, if changed since last report:	N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 2 - Financial Information

Item 2.02 Results of Operations and Financial Condition.

On April 26, 2012, Aetna Inc. issued a press release announcing results for the quarter ended March 31, 2012. A copy of that press release is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 2.02 by reference.

The information in this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.


99.1	Press release of Aetna Inc. dated April 26, 2012 announcing results for the quarter ended March 31, 2012.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



	Aetna Inc.



Date: April 26, 2012	By:	/s/ Rajan Parmeswar
		Name: Rajan Parmeswar
		Title: Vice President, Controller and Chief Accounting Officer



Exhibit Number	Description

Exhibit 99.1	Press release of Aetna Inc. dated April 26, 2012 announcing results for the quarter ended March 31, 2012.

EX-99.1 2 exhibit99_1.htm PRESS RELEASE 2012 Q1 Earnings Press Release



	151 Farmington Avenue Hartford, Conn. 06156	Media Contact: Cynthia Michener 860-273-8553 michenerc@aetna.com
		Investor Contact: Tom Cowhey 860-273-2402 cowheyt@aetna.com

News Release _________________________________________________________

AETNA REPORTS FIRST-QUARTER 2012 RESULTS


•	First-quarter 2012 operating earnings per share ⁽¹⁾ were $1.34


•	Net income per share was $1.43


•	Total medical benefit ratio was 81.5 percent in the first quarter 2012


•	Medical membership totaled 17.9 million members at March 31, 2012


•	Aetna reaffirms full-year 2012 projected operating earnings per share of approximately $5.00 ⁽²⁾

HARTFORD, Conn., April 26, 2012 - Aetna (NYSE: AET) today announced first-quarter 2012 operating earnings ⁽¹⁾ of $477.4 million, or $1.34 per share. This operating result compares to the $1.14 per share reported in the first quarter of 2011, excluding the impact of favorable prior-years reserve development in 2011. The increase in first-quarter 2012 operating earnings excluding prior-years development is a continuation of our strong operating performance and the positive momentum in our core business. First-quarter 2011 operating earnings including favorable prior-years reserve development of approximately $112 million were $1.43 per share. There was no significant prior-years reserve development in the first quarter of 2012. Net income for the first quarter of 2012 was $511.0 million, or $1.43 per share, including $.09 per share of net realized capital gains. Net income for the first quarter of 2011 was $586.0 million, or $1.50 per share, including $.07 per share of net realized capital gains.



First-Quarter Financial Results at a Glance

(Millions, except per share results)	2012		2011		Change
Revenue ⁽³⁾	$	8,864.1	$	8,348.1	6	%
Operating earnings	477.4		560.2		(15	)%
Net income	511.0		586.0		(13	)%

Per share results:
Operating earnings	1.34		1.43		(6	)%
Net income	1.43		1.50		(5	)%

Weighted average common shares - diluted	356.8		391.2

Aetna/2

“Our first-quarter results are a good start to the year, and we expect continued strong performance in 2012,” said Mark T. Bertolini, Aetna chairman, CEO and president. “We're balancing growth and profitability, and are confident of our ability to increase membership over the course of this year to 18.2 million medical members. We're seeing positive momentum in our 2013 selling season with early National Accounts wins and new business opportunities that are twice what they were a year ago. Customers are beginning to return to Aetna's integrated solutions that deliver better value and health outcomes.

“Aetna also is taking concrete steps toward our long-term goal of making health care more accessible and affordable. Already this year, we launched our consumer digital platform to give people a personalized, coherent experience to manage their health. We also were privileged to be awarded Medicaid contracts in Missouri and Ohio to help their at-risk populations access high-quality, cost-effective care,” said Bertolini.

“Aetna's results in the first quarter are evidence of the rigor with which we manage our business,” said Joseph M. Zubretsky, Aetna senior executive vice president and CFO. “In addition to strong commercial underwriting margins, Aetna posted 6 percent year-over-year revenue growth. Our financial position, capital structure, and liquidity all continue to be very strong.

“We're executing on the core business and expanding our emerging business, where we're advancing our goal of transforming the network model to address the nation's health care cost and quality challenges. Our fast-growing base of opportunities with health systems around the country reflects the value that providers see in Aetna's Accountable Care Solutions business. We believe Aetna's strategy to invest in innovation that improves health care delivery and to capitalize on opportunities for profitable growth will enable us to continue generating operating earnings growth,” said Zubretsky.

Aetna/3

Health Care business results

Health Care, which provides a full range of insured and self-insured medical, pharmacy, dental and behavioral health products and services, reported:

•

Operating earnings of $468.9 million for the first quarter of 2012, compared with $443.4 million, excluding the impact of favorable prior-years reserve development for the corresponding period in 2011. This increase in first quarter 2012 operating earnings was primarily due to higher Medicare Advantage underwriting margins. Operating earnings in the first quarter of 2011, including the impact of approximately $112 million after tax of favorable prior-years reserve development, were $555.3 million. There was no significant prior-years reserve development in the first quarter of 2012.

•

Revenues⁽³⁾ of $8.20 billion for the first quarter of 2012, compared with $7.71 billion for the first quarter of 2011. The increase is due to higher Health Care premium primarily from higher Commercial premium yields, higher Medicare premium from Medicare Advantage membership growth and the addition of Genworth's Medicare Supplement business, and higher fees and other revenue primarily from the inclusion of revenues from our other 2011 acquisitions. Total Revenue for the first quarter of 2012, which includes net realized capital gains, was $8.24 billion compared with $7.74 billion for the first quarter of 2011.


•	Medical benefit ratios (MBRs) for the first quarters of 2012 and 2011 were as follows:



	2012		2011
Commercial	79.9	%	77.0	%	^(b)
Medicare	84.4	%	85.1	%	^(c)
Medicaid	91.6	%	88.5	%	^(d)
Total	81.5	%	79.2	%	^(a)


^(a)	Excluding favorable development of prior-years health care cost estimates of approximately $174 million before tax, the Total MBR was 81.8 percent for the first quarter of 2011.


^(b)	Excluding favorable development of prior-years health care cost estimates of approximately $143 million before tax, the Commercial MBR was 79.8 percent for the first quarter of 2011.


^(c)	Excluding favorable development of prior-years health care cost estimates of approximately $25 million before tax, the Medicare MBR was 86.8 percent for the first quarter of 2011.


^(d)	Excluding favorable development of prior-years health care cost estimates of approximately $6 million before tax, the Medicaid MBR was 90.4 percent for the first quarter of 2011.

Aetna/4

•

Sequentially, first-quarter 2012 medical membership decreased by 544,000 to 17.915 million, reflecting previously projected decreases in our Commercial administrative services contract membership and our exit from the Connecticut Medicaid program, partially offset by growth in other businesses; dental membership decreased by 57,000 to 13.613 million and pharmacy benefit management services membership decreased by 177,000 to 8.643 million.


•	Net income was $495.9 million for the first quarter of 2012, compared with $577.2 million for the first quarter of 2011.

Group Insurance business results

Group Insurance, which includes group life, disability and long-term care products, reported:


•	Operating earnings of $40.9 million for the first quarter of 2012, compared with $42.9 million for the first quarter of 2011.


•	Net income of $48.8 million for the first quarter of 2012, compared with $47.1 million for the first quarter of 2011.


•	Revenues⁽³⁾ of $532.0 million for the first quarter of 2012, compared with $504.4 million for the first quarter of 2011. First-quarter Total Revenue, which includes net realized capital gains, was $544.2 million in 2012 and $510.9 million in 2011.

Large Case Pensions business results

Large Case Pensions, which manages a variety of discontinued and other retirement and savings products, primarily qualified pension plans, reported:


•	Operating earnings of $5.8 million for the first quarters of both 2012 and 2011.


•	Net income of $4.5 million for the first quarter of 2012, compared with $5.5 million for the first quarter of 2011.

Total company results


•	Revenues⁽³⁾for the first quarter of 2012 were $8.86 billion, compared with $8.35 billion for the first quarter of 2011. The increase is primarily the result of higher Health Care premium and higher fees and other revenue. Total Revenue, which includes net realized capital gains, was $8.92 billion and $8.39 billion for the first quarters of 2012 and 2011, respectively.

Aetna/5


•	Operating Expenses ⁽¹⁾ were $1.67 billion for the first quarter of 2012. The business segment operating expense ratio ⁽⁴⁾ was 18.8 percent in the first quarter of 2012 and 18.7 percent in the first quarter of 2011. Including net realized capital gains, these ratios were 18.7 percent and 18.6 percent for the first quarters of 2012 and 2011, respectively.


•	Corporate Financing Interest Expense was $38.5 million and $43.0 million after tax for the first quarters of 2012 and 2011, respectively.


•	Net Income was $511.0 million for the first quarter of 2012 compared with $586.0 million for the first quarter of 2011.


•	Pre-tax Operating Margin ⁽⁵⁾ was 9.4 percent for the first quarter of 2012 compared with 11.4 percent for the first quarter of 2011. For the first quarter of 2012, the after-tax net income margin was 5.7 percent compared to 7.0 percent for 2011.


•	Share Repurchases totaled 7.4 million shares at a cost of $344 million in the first quarter of 2012.

Aetna's conference call to discuss first-quarter 2012 results will begin at 8:30 a.m. ET today. The public may access the conference call through a live audio webcast available on Aetna's Investor Information link on the Internet at www.aetna.com. Financial, statistical and other information, including GAAP reconciliations, related to the conference call also will be available on Aetna's Investor Information website.

The conference call also can be accessed by dialing 800-967-7135 or +1-719-457-2710 for international callers. The company suggests participants dial in approximately 10 minutes before the call. The access code is 1470071. Individuals who dial in will be asked to identify themselves and their affiliations.

A replay of the call may be accessed through Aetna's Investor Information link on the Internet at www.aetna.com or by dialing 888-203-1112, or +1-719-457-0820 for international callers. The replay access code is 1470071. Telephone replays will be available from 11 a.m. ET on April 26, 2012, until 11 p.m. ET on May 10, 2012.

Aetna/6

About Aetna

Aetna is one of the nation's leading diversified health care benefits companies, serving approximately 36.1 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities, Medicaid health care management services and health information technology services. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com.

Aetna/7



Consolidated Statements of Income


	For the Three Months
	March 31,
(Millions)	2012		2011
Revenue:
Health care premiums	$	7,187.4	$	6,750.6
Other premiums	476.4		445.3
Fees and other revenue	959.7		899.6
Net investment income	240.6		252.6
Net realized capital gains	51.7		39.7
Total revenue	8,915.8		8,387.8

Benefits and expenses:
Health care costs	5,857.5		5,348.0
Current and future benefits	510.9		485.5
Operating expenses:
Selling expenses	285.8		290.7
General and administrative expenses	1,380.2		1,272.8
Total operating expenses	1,666.0		1,563.5
Interest expense	59.3		66.1
Amortization of other acquired intangible assets	37.8		26.3
Total benefits and expenses	8,131.5		7,489.4

Income before income taxes	784.3		898.4
Income taxes	273.3		312.4
Net income	$	511.0	$	586.0

Aetna/8



Summary of Results


	For the Three Months
	Ended March 31,
(Millions)	2012		2011
Operating earnings, excluding prior-years development ⁽¹⁾			$	448.3
Favorable development of prior-years health care cost estimates			111.9
Operating earnings	$	477.4	560.2
Net realized capital gains	33.6		25.8
Net income (GAAP measure)	$	511.0	$	586.0

Weighted average common shares - basic	350.3		383.5

Weighted average common shares - diluted	356.8		391.2

Per Common Share
Operating earnings, excluding prior-years development ⁽¹⁾			$	1.14
Favorable development of prior-years health care cost estimates			.29
Operating earnings	$	1.34	1.43
Net realized capital gains	.09		.07
Net income (GAAP measure)	$	1.43	$	1.50

Aetna/9



Segment Information ⁽⁶⁾

	For the Three Months
	Ended March 31,
(Millions)	2012			2011
Health Care:
Revenue, excluding net realized capital gains	$	8,201.1		$	7,709.7
Net realized capital gains	41.6			33.7
Total revenue (GAAP measure)	$	8,242.7		$	7,743.4

Commercial Medical Benefit Ratio: ⁽¹⁾
Premiums	$	5,177.1		$	5,013.6
Health care costs (GAAP measure)	$	4,135.0		$	3,859.4
Favorable development of prior-years health care cost estimates				142.7
Health care costs, excluding prior-years development				$	4,002.1

Commercial MBR (GAAP measure)	79.9		%	77.0		%
Commercial MBR, excluding prior-years reserve development				79.8		%

Medicare Medical Benefit Ratio: ⁽¹⁾
Premiums	$	1,651.6		$	1,408.8
Health care costs (GAAP measure)	$	1,393.9		$	1,198.3
Favorable development of prior-years health care cost estimates				24.5
Health care costs, excluding prior-years development				$	1,222.8

Medicare MBR (GAAP measure)	84.4		%	85.1		%
Medicare MBR, excluding prior-years reserve development				86.8		%

Medicaid Medical Benefit Ratio: ⁽¹⁾
Premiums	$	358.7		$	328.2
Health care costs (GAAP measure)	$	328.6		$	290.3
Favorable development of prior-years health care cost estimates				6.3
Health care costs, excluding prior-years development				$	296.6

Medicaid MBR (GAAP measure)	91.6		%	88.5		%
Medicaid MBR, excluding prior-years reserve development				90.4		%

Total Medical Benefit Ratio: ⁽¹⁾
Premiums	$	7,187.4		$	6,750.6
Health care costs (GAAP measure)	$	5,857.5		$	5,348.0
Favorable development of prior-years health care cost estimates				173.5
Health care costs, excluding prior-years development				$	5,521.5

Total MBR (GAAP measure)	81.5		%	79.2		%
Total MBR, excluding prior-years reserve development				81.8		%

Operating earnings,⁽¹⁾ excluding prior-years development				$	443.4
Favorable development of prior-years health care cost estimates				111.9
Operating earnings	$	468.9		555.3
Net realized capital gains	27.0			21.9
Net income (GAAP measure)	$	495.9		$	577.2

Aetna/10



Segment Information continued ⁽⁶⁾

	For the Three Months
	Ended March 31,
(Millions)	2012			2011

Group Insurance:
Revenue, excluding net realized capital gains	$	532.0		$	504.4
Net realized capital gains	12.2			6.5
Total revenue (GAAP measure)	$	544.2		$	510.9

Operating earnings	$	40.9		$	42.9
Net realized capital gains	7.9			4.2
Net income (GAAP measure)	$	48.8		$	47.1

Large Case Pensions:
Revenue, excluding net realized capital losses	$	131.0		$	134.0
Net realized capital losses	(2.1		)	(.5		)
Total revenue (GAAP measure)	$	128.9		$	133.5

Operating earnings	$	5.8		$	5.8
Net realized capital losses	(1.3		)	(.3		)
Net income (loss) (GAAP measure)	$	4.5		$	5.5



Total Company:
Revenue, excluding net realized capital gains (A)	$	8,864.1		$	8,348.1
Net realized capital gains	51.7			39.7
Total revenue (GAAP measure) (B)	$	8,915.8		$	8,387.8

Business segment operating expenses (C)	$	1,666.6		$	1,562.3
Corporate Financing segment operating (benefit) expense ⁽⁷⁾	(.6		)	1.2
Total operating expenses (GAAP measure) (D)	$	1,666.0		$	1,563.5


Operating Expenses Ratios:
Business segment operating expense ratio (C)/(A)	18.8		%	18.7		%
Total operating expense ratio (D)/(B) (GAAP measure)	18.7		%	18.6		%

Aetna/11



Membership

	March 31,	December 31,	March 31,
(Thousands)	2012	2011	2011
Medical Membership:
Commercial	16,136	16,626	16,175
Medicare Advantage	434	398	395
Medicaid	1,174	1,272	1,212
Medicare Supplement	171	163	12
Total Medical Membership	17,915	18,459	17,794

Consumer-Directed Health Plans ⁽⁸⁾	2,560	2,387	2,412

Dental Membership:
Commercial	12,003	12,071	11,881
Medicare & Medicaid	637	652	626
Network Access ⁽⁹⁾	973	947	982
Total Dental Membership	13,613	13,670	13,489

Pharmacy Benefit Management Membership:
Commercial	7,869	8,177	7,901
Medicare Prescription Drug Plan (stand-alone)	469	427	447
Medicare Advantage Prescription Drug Plan	198	189	190
Medicaid	107	27	27
Total Pharmacy Benefit Management Services	8,643	8,820	8,565

Aetna/12



Operating Margins

	For the Three Months
	Ended March 31,
(Millions)	2012			2011
Reconciliation to Income Before Income Taxes:
Operating earnings ⁽¹⁾before income taxes, excluding interest
expense and amortization of other acquired intangible assets (A)	$	829.7		$	951.1
Interest expense	(59.3		)	(66.1		)
Amortization of other acquired intangible assets	(37.8		)	(26.3		)
Net realized capital gains	51.7			39.7
Income before income taxes (GAAP measure)	$	784.3		$	898.4

Reconciliation to Net Income:
Operating earnings,⁽¹⁾ excluding interest expense and
amortization of other acquired intangible assets, net of tax	$	540.5		$	620.3
Interest expense, net of tax	(38.5		)	(43.0		)
Amortization of other acquired intangible assets, net of tax	(24.6		)	(17.1		)
Net realized capital gains, net of tax	33.6			25.8
Net income (GAAP measure) (B)	$	511.0		$	586.0

Reconciliation of Revenue:
Revenue, excluding net realized capital gains (C)	$	8,864.1		$	8,348.1
Net realized capital gains	51.7			39.7
Total revenue (GAAP measure) (D)	$	8,915.8		$	8,387.8

Operating and Net Income Margins:
Pretax operating margin (A)/(C)	9.4		%	11.4		%
After-tax net income margin (B)/(D) (GAAP measure)	5.7		%	7.0		%

Aetna/13

⁽¹⁾Operating earnings and operating earnings per share exclude from net income net realized capital gains and losses and other items, if any, that neither relate to the ordinary course of our business nor reflect our underlying business performance. Although the excluded items may recur, management believes that operating earnings and operating earnings per share provide a more useful comparison of Aetna's underlying business performance from period to period. Management uses operating earnings to assess business performance and to make decisions regarding Aetna's operations and allocation of resources among Aetna's businesses. Operating earnings is also the measure reported to the Chief Executive Officer for these purposes.

For the periods covered in this press release, the following item is excluded from operating earnings because we believe it neither relates to the ordinary course of our business nor reflects our underlying business performance:


•	Net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of liabilities. However, these transactions do not directly relate to the underwriting or servicing of products for customers and are not directly related to the core performance of Aetna's business operations.

This press release also includes presentations of operating earnings, operating earnings per share, health care costs and medical benefit ratios for the three months ended March 31, 2011 excluding development of prior-years health care cost estimates. Management believes these measures provide a useful comparison of Aetna's underlying business performance from period to period where there are significant differences in prior-years development from period to period.

For a reconciliation of these items to financial measures calculated under U.S. generally accepted accounting principles (“GAAP”), refer to the tables on pages 8 through 10 and 12 of this press release.

⁽²⁾Projected operating earnings per share exclude from net income any future net realized capital gains and losses and other items, if any, that neither relate to the ordinary course of our business nor reflect our underlying business performance. Aetna is not able to project the amount of future net realized capital gains and losses or any such other items and therefore cannot reconcile projected operating earnings per share to projected net income per share in any period. Projected operating earnings per share for the full year 2012 reflect a range of approximately 350 million to 353 million weighted average diluted shares.

⁽³⁾ Revenue excludes net realized capital gains and losses as noted in ⁽¹⁾ above. Refer to the tables on pages 9, 10 and 12 of this press release for a reconciliation of revenue excluding net realized capital gains and losses to revenue calculated under GAAP.

⁽⁴⁾The business segment operating expense ratio reflects the exclusion of the Corporate Financing segment from operating expenses and excludes net realized capital gains and losses and other items, if any. For a reconciliation of this metric to the comparable GAAP measure refer to page 10 of this press release.

⁽⁵⁾In order to provide useful information regarding Aetna's profitability on a basis comparable to others in the industry, without regard to financing decisions, income taxes or amortization of other acquired intangible assets (each of which may vary for reasons not directly related to the performance of the underlying business), Aetna's pretax operating margin is based on operating earnings excluding interest expense, income taxes and amortization of other acquired intangible assets. Management also uses pretax operating margin to assess Aetna's performance, including performance versus competitors.

⁽⁶⁾ Revenue and operating expense information is presented before income taxes. Operating earnings is presented net of income taxes.

⁽⁷⁾Our Corporate Financing segment is not a business segment. It is added to our business segments to reconcile to our consolidated results. The Corporate Financing segment includes interest expense on our outstanding debt and the financing components of our pension and other postretirement benefit plan expenses (benefits).

⁽⁸⁾ Represents members in consumer-directed health plans included in Aetna's Commercial medical membership.

⁽⁹⁾ Represents members in products that allow these members access to Aetna's dental provider network for a nominal fee.

Aetna/14

CAUTIONARY STATEMENT; ADDITIONAL INFORMATION -- -- Certain information in this press release is forward-looking, including our projections as to operating earnings per share, medical membership, operating earnings growth and weighted average diluted shares. Forward-looking information is based on management's estimates, assumptions and projections, and is subject to significant uncertainties and other factors, many of which are beyond Aetna's control. Important risk factors could cause actual future results and other future events to differ materially from those currently estimated by management, particularly the implementation of health care reform legislation and changes in Aetna's future cash requirements, capital requirements, results of operations, financial condition and/or cash flows. Health care reform will significantly impact our business operations and financial results, including our medical benefit ratios. Components of the legislation will be phased in over the next six years, and we will be required to dedicate material resources and incur material expenses during that time to implement health care reform. Many significant parts of the legislation, including health insurance exchanges, the scope of "essential benefits," employer penalties and the implementation of minimum medical loss ratios, require further guidance and clarification both at the federal level and/or in the form of regulations and actions by state legislatures to implement the law. In addition, the pending U.S. Supreme Court ruling on the constitutionality of health care reform and the 2012 presidential election create additional uncertainty about the ultimate impact of health care reform. As a result, many of the impacts of health care reform will not be known for the next several years. Other important risk factors include adverse and less predictable economic conditions in the U.S. and abroad (including unanticipated levels of, or increases in the rate of, unemployment); adverse changes in health care reform and/or other federal or state government policies or regulations as a result of health care reform or otherwise (including legislative, judicial or regulatory measures that would affect our business model, restrict funding for or amend various aspects of health care reform, limit our ability to price for the risk we assume and/or reflect reasonable costs or profits in our pricing, such as mandated minimum medical benefit ratios, eliminate or reduce ERISA pre-emption of state laws (increasing our potential litigation exposure) or mandate coverage of certain health benefits); our ability to differentiate our products and solutions from those offered by our competitors, and demonstrate that our products lead to access to better quality of care by our members; unanticipated increases in medical costs (including increased intensity or medical utilization as a result of flu, increased COBRA participation rates or otherwise; changes in membership mix to higher cost or lower-premium products or membership-adverse selection; changes in medical cost estimates due to the necessary extensive judgment that is used in the medical cost estimation process, the considerable variability inherent in such estimates, and the sensitivity of such estimates to changes in medical claims payment patterns and changes in medical cost trends; increases resulting from unfavorable changes in contracting or re-contracting with providers, and increased pharmacy costs); failure to achieve and/or delays in achieving desired rate increases and/or profitable membership growth due to regulatory review or other regulatory restrictions, the difficult economy and/or significant competition, especially in key geographic areas where membership is concentrated, including successful protests of business awarded to us; adverse changes in size, product mix or medical cost experience of membership; our ability to diversify our sources of revenue and earnings; adverse program, pricing or funding actions by federal or state government payors, including curtailment or elimination of the Centers for Medicare & Medicaid Services' star rating bonus payments; the ability to reduce administrative expenses while maintaining targeted levels of service and operating performance; the ability to successfully implement our agreement with CVS Caremark Corporation on a timely basis and in a cost-efficient manner and to achieve projected operating efficiencies for the agreement; our ability to integrate, simplify, and enhance our existing information technology systems and platforms to keep pace with changing customer and regulatory needs; the success of our health information technology initiatives; the ability to successfully integrate our businesses (including Medicity, Prodigy Health Group, PayFlex, and Genworth Financial Inc.'s Medicare Supplement business and other businesses we acquire in the future) and implement multiple strategic and operational initiatives simultaneously; managing executive succession and key talent retention, recruitment and development; the outcome of various litigation and regulatory matters, including guaranty fund assessments and litigation concerning, and ongoing reviews by various regulatory authorities of, certain of our payment practices with respect to out-of-network providers and/or life insurance policies; reputational issues arising from our social media activities, data security breaches, other cybersecurity risks or other causes; the ability to develop and maintain relations with providers while taking actions to reduce medical costs and/or expand the services we offer; our ability to maintain our relationships with third party brokers, consultants and agents who sell our products; increases in medical costs or Group Insurance claims resulting from any epidemics, acts of terrorism or other extreme events; and a downgrade in our financial ratings. For more discussion of important risk factors that may materially affect Aetna, please see the risk factors contained in Aetna's 2011 Annual Report on Form 10-K ("Aetna's Annual Report") on file with the Securities and Exchange Commission (the “SEC”) and Aetna's Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 ("Aetna's Quarterly Report") when filed with the SEC. You also should read Aetna's Annual Report and Aetna's Quarterly Report for a discussion of Aetna's historical results of operations and financial condition.

GRAPHIC 3 aetnalogo.jpg AET LOGO begin 644 aetnalogo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBFRR"*)Y&^ MZBEC^%`'-7'CO2[:YE@:"[9HG*$JBX)!QQ\U1?\`"P=)_P"?>]_[X3_XJO.) M':21I&^\Q)/U--K7D1P/$S/2?^%@Z3_S[WO_`'PG_P`51_PL'2?^?>]_[X3_ M`.*KS:BGR(7UF9Z3_P`+!TG_`)][W_OA/_BJOZ3XKL=9O?LMM#?#E<1ZBV>IC&/IN_QJ9;& MV'_B([FBBBL3T0HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`*\L\:WXO?$,D:G*6RB(?7J?U./PKT76-1 M32M*GNWQE%^0'^)CT'YUXU)(\LKR2,6=R68GN36D%U.7$SLE$;1116AQ!111 M0`5Z'\.U(TV\;L9@/R'_`->O/*](^'J@:'<-W-R1_P".K_C4SV-\-\9UM%%% M8GH!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`445'+<0P+F::.,>KL!_.@"2 MBLJ;Q-HL&=^I0'']P[_Y9JC+XYT2/[LLTO\`N1'^N*?*R7.*W9T=%WI]SN:*XR/XB6A`\RQG4]]K!O\*N1>/-&D/S_`&B+_?CS_(FC ME92JP[G3T5DV_B;1;HXCU&$'_IH2G_H6*U$=)%#(RLIZ%3D5-BTT]AU%%%`P MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHJ*>ZM[5=UQ M/%$OK(X4?K0!+16-/XKT.W.&U"-C_P!,U+_R%4)?'NCQGY5N9/\`=C']2*?* MR'4@MV=117&O\1+(9V6,[<<;F`Y_6H#\1EQ\NEDGWGQ_[+3Y&3[:GW.YHKA? M^%C_`/4*_P#)C_[&E'Q&3'.F,#[3_P#V-'(P5>F^IW-%<HP#/0.VS_T+%:2. MDBAD964]"IR*5K%II[#J***!A1110`4444`%%%%`!1110`4444`%%%E^`!_P`4])[W#?\`H*UYI7I_@1`O MAM2/XIG)_0?TJ9O0Z,+\9TU%%%8G>%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!12$A1DD`>IJM+J=A"<2WUM'_ORJ/ZT`6J*R9?$VBQ?>U&`_[IW?RJ MK)XUT)/NW3O_`+L3?U`IV9+G%;LZ"BN5?X@:0I^6&[;Z(O\`5J@;XAV(QMLK M@^N2HI\K)]K#N=C17#M\1H^=NF,?3,V/_9:;_P`+'_ZA7_DQ_P#8TGW M.ZHKA?\`A8__`%"O_)C_`.QI5^(R_P`6ED?2?/\`[+1R,/;T^YW-%<8GQ$LS M_K+&=?\`=8'_``JW%X]T>0X=;F+W>,'^1-'*QJK#N=1161!XIT2YQLU")3_T MTRG_`*%BM.*>*=-\,J2+ZHP(_2IL6FGL24444#"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHJM/J-C;'$]Y;Q'T>4#^9H`LT5BS>+-#@^]?HQ]$5F_ MD*I2^/-&C/RBYE_W(Q_4BG9D.I%;LZ>BN.?XAV`/R65RP_VBH_J:KGXC+CY= M+)/O/C_V6GR,GVU/N=S17!M\1G/W=+4?6?/_`++3?^%BR_\`0-3_`+_'_"CD M8O;T^YWU%<$OQ&?/S:8I'M-C_P!EJ5/B,A)WZ8R_[L^?_911R,/;T^YW%%<@ MGQ#TX_ZRTNE_W=I_J*NP^-]$EQNGEB)_OQ'^F:7*RE5@^IT5%4+;6]+NR!!? MV[L>B^8`WY'FK](T3N%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%0W-W;V<1EN9XX4_O.P`J:O*?&A;_A*;H,Q(PFT9Z?(*J,;F=6IR1N M==?>.]+MB5MUENG'=1M7\S_A7/W?C_4ILBVAAMU]2-[?F>/TKDJ*T4$<4L1- M]32N?$&KW>1-J$Y!ZJK;0?P&!6ZN+5]]O/)$WK&Q4_I45%`7L=+8>.-6M"%G9+J/TD M&&_,?US77Z5XRTS4BLT%Q:2;EZ,IX93Z$5FXM'93JQGL7** M**DU"BBB@`HHHH`****`"BBB@`HHHH`**K7U_:Z;;&XNYEBC'<]3[`=S7`ZS MXZNKO=#IRFVAZ>8?]8P_]E_G[TU%LSG4C#<[G4-7L-+3=>7*1D]%ZL?H!S7* M:A\0E!*:=:9]))S_`.RC_&N%DD>60R2.SNW)9CDG\:;6B@CDEB9/;0V+WQ3K M-\3OO7C0_P`$/R#].3^-9#,SL69BS'J2["BBB@04444`%%%%` M!1110`5+;W5Q:OOMYY(F]8V*G]*BHH"]CI+'QOK%H0)9$N4])5Y_,8_7-=7I MOCC3+TJEQNM)3_ST.4_[Z_QQ7F%%2XIFT*\X^9[FDB2HKQNKHPR&4Y!%.KQO M2M=U#1Y-UI,0A.6B?E&_#_"O1]"\46>M*(_]1=`ZGO_.LW%HZZ=>,] M.INT445)L%%%%`!14-W=P6-K)/=2N`5M8XK53W'SM M^9X_2N:N;JXO)C+O>.);I7MM,#0Q'@S'AV' MMZ#]?I7'445HE8XYSE-W84444R0HHHH`****`"NATGQ==Z/IZV<%O`ZABVY\ MYY^AKGJ*+7*C-Q=XG7_\+"U+_GTM/R;_`!H_X6%J7_/I:?DW^-P>&O\`D6[#_KD*B:.C#U)3;YF:M%%% M9G4%9VNZC)I6BW%[$BN\>W"MT.6`_K6C61XI7?X9OQG'[O/3T(--;BE>SL<; M_P`+!U;_`)][+_OA_P#XJD;X@:N1Q#9K]$;_`.*KE**VY4>;[:?LL> M#;KQVC_Q-5V\9Z\W2]"_2)/\*P:*+(/:S[FM)XGUN4$-J,PS_=(7^559-7U* M7/F:A=.#V:9C_6J=%%D2YR>['/(\AR[LQZY8YIM%%,D****`"BBB@`HHHH`* M***`"BBB@`I\4LD,@>*1HW'1E."*910!OV/C'6;(@&X%P@_AG&[]>OZUU.F^ M/;"Y*I>QM:N>-P^9/SZC\J\WHJ7%,UC7G'J>Y0S17$2RPR))&PR&0Y!_&GUX MSIFLWVD3>9:3E03\T9Y1OJ/Z]:])T#Q/:ZVOED>3=J,M$3U]U/>LW%H[*=>, M]-F;M%%%2;!1110`4444`%%%%`!5&^UG3M-!^UW<4;#^#.6_(]5&-S&M5]G:R/0;SXA6L>5L[.28]-TC!!]>Y_E6#= M^.-9N,B*2*W7TC3)Q]3FN;HK111QRKSEU+=SJ=_>9%S>3R@]GD)'Y54HHJC- MMO<****!!1110`4444`%%%%`!1110`5OZ;JXQ:W`,F,F)_E.TY' M:-PZ,593D,IP0:AP3-X8F2WU/OU MKOHY$EC62-U=&&593D$5FTT=D*D9JZ'4444BPKD-:\830Z@VG:3;">X5MC,0 M6^;N%`ZUU]>7+]L5\C."6BP/S!XKJM"UN#7+'SXE,A:I;O;RSF$2J M59)UQP>.O(_6K.@Z!8Z/YD]C<33).HR6=64@=",`>IH>P0OS:.Z.;U/QQJ=E MJEU:QP6A2&5D4LC9(!QS\U=M8W27UC!=1_=E0.!Z9'2O,;NP;4?%NI6R@^87 MF9!ZD`L!^./UKJ/`.H?:-*ELG;+V[Y4?[+<_SS53BEL33G+G:>SV-7Q+K3:) MI?GQ*C3NX2-7!(]3G!'85F^%?$][KE]-!6K`DY`[D^M9OBIFUGQ M79:1&3MCP'QV+3JZ;'HM%%%9G0%%% M%`!7E_CI=OB1CC[T2'^G]*]0KS7X@+MU^%N?FME/_CS5<-S#$_`TZ7J4&K6$=W;GY6X*GJK=P:N5Y3X3UPZ/J825\6DY"R`GA M3V;\/Y5ZM6,E9GHTJG/&X4445)J%%%%`!1110`4444`%8VO^([70X,-B2Z8? M)"#S]3Z"CQ%K\6AV6[A[F3(BCS^I]A7E%SJW1N+N4NW\(_A4>@'853HHK4X&VW=A1110(****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"G([1NKHQ5U.0RG!!IM%`'I'A7Q7_:.VQOV`NQ M]Q^@D_\`K_SKK:\+1VC=71BK*<@@\@UZOX6UT:UIO[P@74.%E'KZ-^/\\UE. M-M4=U"KS>[+P>&O^1;L M/^N0KQ^O8/#7_(MV'_7(5G4.K"[LU:***S.T*S?$"[_#VH#&?]'<_D,UI51U MD;M"U!1U-M(/_'336XI;,\8HHHK<\D****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"G1R/#*LD;LCH_K_G'2UX?:W,UGPZ/J<>KZ9#=QX!88=1_ M"PZBLI1MJ>A0J\ZL]R_1114&X4444`%%%%`!7A;+M=EZX.*]TKQ*^3R]0N4Q MC;*PQZ8)K2GU.3%;(KT445H<84444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!73>%?$SZ3.MI!=<-Q`=*N&S)$NZ$GNO_:RGT! MZ8]C35B:CDK-*Z-._P#`VDW,;&W5[67'!1B5S[@]OIBL3X?WDR:E&?#2Z%$\DKK)=RC#,O1 M1Z#_`!IO169FE>:E%6.;TG_DI4__`%VF_DU.CE7PQXZF$C;+2?))[;6Y'Y,, M5JZ?X?O[;QC-J;K']F=Y&!#\X;..*E\7>')]9-M-9A//CRC[CC*]1S['/YU4 MI)L'"5KI:IF=X+A?4=9U#69@>6*K]6.3^0P/QJIX"_Y#]Y_UQ/\`Z$*[#P]I M9T?1H;5]OF\O(5[L?\@?A6+X5\.W^D:K6LD7HQ&5/T(XJG5&;36C"BBB@04444`%%%%`!1110`5Z MOX0U0ZEH48D;,T!\I\]\=#^7\C7E%=7X"OOL^M/:D_)?+.W<]*HHHK$]`****`"BBB@`JM?WL.G6,MW<-B.-<^.M9^U M7RZ="^8;K^GX#^9IQ5V9U)\D;G.:IJ4^JZA+=W!^9SPN>%7L!5.BBMS MS6VW=A1110(****`"BBB@`HHK?T/PG>ZR!,W^CVO_/5QDM_NCO\`6DW;?YC^73]*V8XHX5VQ1JB^BC`J>='1' M"OJSP\HRC+*0/<4VO=2,C!Z5G7F@Z5?@_:+&$L?XU7:WYCFCVB&\+V9XW176 M>(/!O'45R=4FGLP>&O^1;L M/^N0KQ^O8/#7_(MV'_7(5G4.K"[LU:***S.T*K:BGF:9=QYQNA#LU3Z!H/Z[J7-'N5]7J=CA:*ZF[\!:M`I M:!H+@>BMM;]>/UKG+FUN+.4Q7,,D,@_A=2#333(E3E'=$-%%%,@****`"BBB M@`HHHH`*ZSP)JGV75&L9&_=7(^7/9QT_,9_2N3J2WG>VN(IXCB2-@ZGW!S2: MNK%TY\DDSW&BHK:=+JUAN(_N2H''T(S4M8'J!1110`4444`%>,:TNS7=07GB MYDQG_>->SUX]XD79XCU`9S^^8],=>:N&YS8I>ZC+HHHK4X0HHI\4,L\@2&-Y M'/144D_I0`RBMFV\*:W<@%;!T4]Y2$Q^!.:U8/A]J3\S7-M&/0$L?Y4KHT5* M;V1R-%=TOPY/\>J`>P@_^RIY^'*8XU-L_P#7'_[*ES1[E?5ZG8X*BNWD^',H M'[O4D8_[4)7^IK,NO`^LVX+(D5P!_P`\GY_(XHYD)T:BZ'-T5+/;S6LIBN(7 MBD'574@_K45496L%%%%`!1110`4444`%%%%`%G3[V33K^"[B^_$X;'J.X_$< M5[1;SQW-O%/$BBBLCM"BBB@`HHHH`****`"BBB@`HHHH`*X?XC+F+3FP>&D&?KM_PKN* MQ/$6@MKT=K%YPB2.0LYQDXQV]ZJ+L[D58N4&D>2UN:;X2U;4MK"#R(C_`,M) MOE_(=37H>E^&],TG#06X:8?\M9/F;\/3\*UJIS['/#"K[3.1L/`%A!AKV:2Y M;^ZOR+^G/ZUT=IIEC8#%K:0Q>ZJ,_GUJW14-MG1&$8[(****184444`%%%%` M#9(TEC:.1%=&&"K#((^E<-XF\&)'$]]I28"C=);CGCN5_P`/R]*[NBFFT1." MFK,\*HKI?&FC#3=5%Q"N+>ZRP`Z*W?TS5.B@:=G<]UHJMI\QN=-M9SUDA1_S`-6 M:YSU@HHHH`****`*.KZ@NEZ5<7C8)C7Y0>['@#\Z\:DD>65Y)&+.Y+,3W)KN M?B%J!`M=.1NO[Z0?HO\`7]*X2M8+0X,3*\K=@HHHJSG"BBB@`HHHH`***FM; M:2\NXK:(9DE<(OU-`)7T.A\(^'!JUP;NZ7_0XCT/_+1O3Z>M>FJJH@55"JHP M`!@`57L+*+3K"&T@&(XEP/<]S^)YJS6$G=GITZ:A&P4444C0****`"O+?&.C M)I6JB6!0MOQ60?J#_(5W->;?#Z3;KDZ M9X:W/'J0R_\`UZ])K&>YZ-!WIHSM>M)[[0[JUM@#-(H"@D#/(SU]J\[_`.$* MUW_GT7_OZO\`C7JM%$96*G2C/5GE7_"%:[_SZ+_W]7_&C_A"M=_Y]%_[^K_C M7JM%5[1]B/JT#PZ>"2VN)8)1B2)RCC.<$'!J.KVM\Z]J/_7U+_Z$:HUHC@:L MPHHHH$%%%%`!1110`5LV?A;5[^TCNK>W5HI!E6\Q1GG'K6-7K7A'_D5K'_=; M_P!"-*3LKF]"FIMIG"_\(5KO_/HO_?U?\:/^$*UW_GT7_OZO^->JT5'M'V.G MZM`\J_X0K7?^?1?^_J_XT?\`"%:[_P`^B_\`?U?\:]5HH]H^P?5H'E7_``A6 MN_\`/HO_`']7_&O1M$M9;+1;2VG`$L<85@#GFK]%3*5RX4HPV"BBBI-`IDH+ M1.HZE2!3Z*`/"J***Z#R`HHHH`****`"BBB@`KU'P,N/#49QC,CG..O->75Z MIX)_Y%>W_P!Y_P#T(U$]CIPOQOT.AHHHK([@HHHH`*J:CIEIJEL8+N$2+V/= M3Z@]JMT4`U<\>U[1)M#OS`YWQ/\`-%)C[P_Q%9=>M^*=+&J:',@7,T0\V+UR M.WXC(KR2MHNZ/.K4^26FP44451B%%%%`!1110`4444`>J^"[K[3X:@4G+0LT M1_`Y'Z$5T%<5\.IBUG?0=DD5_P`P1_[+7:UA)69Z=)W@F%%%%(T"BBB@`KR7 MQ/=0:]:KE[_P='JFOS7]U<$0/MQ%']XX4#D]NG:JBTGJ8UX. M<;(\VA@EN95B@B>21NBHI)/X5TVG>!-2NMKW;I:1GL?F?\AQ^M>@V6G6>G0^ M59VZ0KWVCD_4]3^-6J;F^A$,-%?$/R''YYK?A@AMT" M011Q(/X44*/TJ2BI;;-U%1V04444B@HHHH`****`*M_IUIJ9^)/#,NARB1&,MFYPCGJI_NG_'O7JU07MI#?V(T59U"RDT[4)[27[\3ER.Y`XH`\H\27GV M[Q#>3`Y42;%^B\?TS^-95!.3D]:*Z%H>3)W;84444""BBB@`HHHH`*ZKP%8B MXUM[EAE;:/(_WFX'Z;JY6O1OA[;[-(N9R,&2;;]0`/ZDU,MC:A&\T=?1116) MZ(4444`%%%%`!7,^.W5?#A!ZO,@'UY/]*Z:N#^(=\"UI8*]_P"N\G_H1JI5O5/^ M0O>_]=W_`/0C52MUL>3+=A1113$%%%%`!1110`5ZUX1_Y%:Q_P!UO_0C7DM> MM>$?^16L?]UO_0C4S^$ZL+\3-NBBBL3M"BBB@`HHHH`****`"BBB@#PMEVNR M]<'%)3Y?]<_^\:972]SR7N%%%%(04444`%%%%`!7J_@Q0/"MF1W+D_\`?;5Y M17K'@W_D5++_`+:?^AM43V.G"_&_0W:***R.X****`"BBB@`KQ?6+7[%K%Y; M`86.5@H_V<\?IBO:*\K\;0^5XGN&'_+14?I_L@?TJX;G-BE>-SGJ***U.$** M**`"BBB@`HHHH`[/X=R8U"]CS]Z(-C'H?_KUZ%7F_P`/2?[=N!V-LQ_\>6O2 M*QGN>CAW^[04445)L%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110! MYU\0;,1:I;W:C'GQE6]RO?\`(C\JX^O1_B%$&T:VE[I.!^!4_P"`KSBMH['G M8A6J,****HQ"BBB@`HHHH`*NZ-)Y6MV#_P!VXC/_`(\*I5-:OY=Y#)C.V13^ M1H''XD>WT445SGK!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!112,ZH,LP4>I.*`%HJI)JFGPG$M]:H?]J91_6H3K^D*<'4[3\)0:=F)M M+AA=>P?\)+H MO_02@_[ZKQ^K@W_WG_P#0 MC70URW@_4+*W\-V\JR`_UIZW5NQPL\1/LXJ2R6N?\:7'D>&+A5U?[K!L>AS7'_$2;;IUG#_`'Y2_P"0Q_[-3CN9U7:#//****W/,"BB MB@`HHHH`****`"O5O!D?E^%K4]W+L?\`OHC^E>4UZ]X60)X9L`/^>>?S)-1/ M8Z<*O>;->BBBLCN"BBB@`HJ*>ZM[5-]Q/'$OK(P4?K7,ZGX[T^U4I9*UW+V. M"J#\3R?PII-DRG&.[-_5-3MM)L7NKE\*.%7NY[`>]>0:C?2ZEJ$UY,?GE;./ M0=A^`I^IZK>:O<^?=R[B.%4<*H]`*I5K&-CAK5N?1;!1115&`4444`%%%%`! M112JI9@J@EB<`#J:`/1/A[;&/2[JY(QYLH4>X4?XDUV%4=&L!IFCVMG_`!1I M\^/[QY/ZDU>K!N[/4A'EBD%%%%(L****`/$K_P#Y"-U_UU?^9JO5B_\`^0C= M?]=7_F:KUNMCR9;L****8@HHHH`****`"O6O"/\`R*UC_NM_Z$:\EKUKPC_R M*UC_`+K?^A&IG\)U87XF;=%%%8G:%%%%`!1110`4444`%%%%`'ALO^N?_>-, MJ6Y0QW4R'JKL/UJ*NEZL\F6["BBBD(****`"BBB@`KUKPC_R*UC_`+K?^A&O M):]:$_\BM8_[K?^A&IG$U87XF;=%%%8G:%%%%`!1110`5YK\0%`\01$?Q6 MRD_]]-7I5>;_`!"!_MVW/8VRC_QYJN&YAB/@.2HHHK4\\****`"BBB@`HHHH M`ZSX??\`(?G_`.O5O_0DKTFO./AZ!_;=PW<6Q'_CRUZ/64]ST,/_``PHHHJ# M<****`"BBB@`HHHH`****`"BBB@`HHICS11?ZR5$_P!Y@*`'T52;6=+7[VI6 M8^LZ_P"-0MXBT91DZE;?A(#3LQ7UZ)XMUS3;SP_-!;7DL%%%%`!1110`4444`%%%%`!1110`4444`%%4]1U6RTJ'S;R=8P?NKU9OH M.IKB=4\?W$I,>FPB%/\`GI(-S_@.@_6FHMD3J1AN=_++'#&9)9%C0=6Z^(DIR+2P1?1I7+?H,?SK(N/&FN3D[;E85/\,<8'ZG)_6N?HJ^5&#K3?4O M3:SJ<_\`K=0NF]C*V/RS5)G9VW.Q8^I.:2BF0VWN%%%%`@HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"E+$@`DD#ID]*2B@`HHHH`****`"BBB@ M`HHHH`*TK;Q!JUI"D,%]*D:<*HQ@5FT46&I-;,VO^$MUW_H(/_WPO^%/_P"$ MRU__`)__`/R#'_\`$UA44K(KVD^[-MO%VNL1V=CU+')IM%%,D****`"BBB@`HHHH`****`"NI\$ MZ,;[4_MLJ_Z/;'(R/O/V'X=?RK%TC2;G6;Y;:W'N[D<(OJ:]=T^P@TVRCM+= M=L:#\2>Y/O43E;0Z,/2YGS/9%FBBBLCO"BBB@`HHHH`\-F),TA)R2QY_&F4^ M7_7/_O&F5TO<\F6["BBBD(****`"BBB@`KUKPC_R*UC_`+K?^A&O):]:$_\ MBM8_[K?^A&IG$U87XF;=%%%8G:%%%%`!1110`4444`%%%%`'B5__P`A&Z_Z MZO\`S-5ZL7__`"$;K_KJ_P#,U7K=;'DRW84444Q!1110`4444`%>O>&%"^&K M``8'EY_,FO(:]@\-?\BW8?\`7(5G4.K"[LU:***S.T****`"BBB@`KSGXA?\ MAFV_Z]Q_Z$U>C5YU\0U(U:U;L8,?DQ_QJZ>YCB/X;./HHHK4\X****`"BBB@ M`HHHH`Z_X>_\AFY_Z]S_`.A+7HU><_#W_D,W/_7N?_0EKT:LJFYZ.'_AH*** M*@V"BBB@`HHHH`**Q-7\4Z;I&Z-Y/.N!_P`L8N2/J>@KB-2\:ZK?;EA<6D1[ M1?>Q_O=?RQ5*+9E.M"&C/2;S4;.P3==W,4([;VP3]!U-<]>>/M+@R+=)KD]B M%VK^O/Z5YL\CRN7D=G<]68Y)IM6H+JVT445SGK!1110`4444`%%%%`!1110`4444`%TTTK+<#AI3RJ?3U/Z?6JGB_Q45:33-/?&/EFF4_FH_J?PKA*TC'JSDK5[/E MB2W-S/>3M-<2O+(W5G.345%%:'&%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`445 MB*=:VB^'[W6YL0KL@!^>9A\H^GJ?:NKTCP%#"5FU243-U\F,X4?4]3^E=C%% M'#$L<2*D:C"JHP!6;GV.JGAGO,J:5I-KH]F+>U3'=W/WG/J:O445F=:22L@H MHHH&%%%%`!1110!X8YW.S#H233:**Z#R'J%%%%`!1110`4444`%>M>$?^16L M?]UO_0C7DM>M>$?^16L?]UO_`$(U,_A.K"_$S;HHHK$[0HHHH`****`"BBB@ M`HHHH`\2O_\`D(W7_75_YFJ]23L6N)&)R2Q)_.HZZ+6T/)ENPHHHH$%%%%`! M1110`5[!X:_Y%NP_ZY"O'Z]@\-?\BW8?]C5Y[\.Q_I]Z>_E+_`#KT*LIO4]'#_P`- M!1114&P445'//%:P//.X2)!N9CT`H`2XN(;6!YYY%CB099F.`*\[U_QKR_Z[I_Z$*J5?T3_D/Z=_U]1?^A"ACCNCV:BBBN<]8****`"BBB@` MHHHH`****`"N?\6ZV=(TO9"V+J?Y8_\`9'=O\]S705Y%XFU,ZIKMQ*&S%&?+ MBYXVCO\`B?+`_>$?^R_C^5)M+LV7A;1[``QV22./XYOG.?7G@?A6NJ*BA44*HZ`#`J/:'2L*^K/&DT/5G&5T MR[QZ^2W^%3CPSK3`$:=/SZC%>OT4N=E_58]SQV?P]J]M"\TUA,L:`EFQG`]: MS*]D\0$CP]J!!_Y=W'Z5XW5Q=SGK4U!I(****HQ"BBB@`HHHH`****`)OLES MY?F?9YMA&=VPXQZYIGE2?\\V_*O9=(`71;`#H+>,?^.BKM1SVW1V?55W/#"C M*,LI`]Q3:]UI"`PP0"/0TO:>0?5?,\+HKW!K:!AAH8R/=17"?$&TBADL)8HD M3<'5MJ@9QMQ_,TU.[L14P_)'FN<51115G,%%%%`!1110`4444`%%%>E>%M&T MV\\,VDMQ8P22/OW.R#)^=AUI-V-*=-S=D>:T5[!_PC6B_P#0-@_[YJ-O">AL M/7)J=-"TE#E=,M,^\*G^E+G0?57W/&JL06- MY=?\>]K/+_USC+?RKV:*SM8,>3;0QX_N(!_*IZ7M"EA5U9Y+;^$=;N,$6+1C MUD8+^A.:V;3X>7+8-W>Q1C^[$I8_F<5Z#12YV:+#P1S]CX-T:R(9H#1$C0(BJJC@*HP!3J*ANYLHJ.R"BBB@84444`%%%%`!1110`4444` M>%4445T'D!1110`4444`%%%%`!7K7A'_`)%:Q_W6_P#0C7DM>M>$?^16L?\` M=;_T(U,_A.K"_$S;HHHK$[0HHHH`****`"BBB@`HHHH`\-E_US_[QIE/E_US M_P"\:972]SR9;L****0@HHHH`****`"O8/#7_(MV'_7(5X_7L'AK_D6[#_KD M*SJ'5A=V:M%%%9G:%%%%`!1110`5Y]\1/^/ZQ_ZYM_.O0:\^^(G_`!_6/_7- MOYU4-S&O_#9Q=%%%;'G!1110`4444`%%%%`':?#O_C^OO^N:_P`Z]!KSWX=D M?;[T=_*7^=>A5C/<]&A_#04445)L%>=^.=<-S=?V7;O^YA.9B#]Y_3\/Y_2N MWU>_73-*N;QL9C3Y0>['@#\\5XR[M)(TCL6=B2S'J2:T@NIS8F=ERKJ-HHHK M0X0HHHH`****`"BBB@`HJ>TL[B_N5M[6%I96Z*O^>!7<:7\/XE59-3G+OU\J M(X4?4]3^&*3DD:0I2GL:O5'M#H6%[L\<3P_K#D`:9=<^L1'\ZE_X1?6_P#H'3?I_C7KU%'.5]5A MW/%KW2K_`$Y5:\M9(58X!8<$U3KT/XB?\@ZS_P"NI_E7GE7%W1RU8*$K(*** M*9F%%%%`!1110`5I^'E+>(M/`_Y[J?R.:S*V/"J[O$]@,X_>$_D":&[:ET_C M1Z[1117.>H%%%%`!1110`4444`%%%%`%#6KLV.B7ERIPR1':?]H\#]2*\9KU M#QU-Y7AITSCS943Z_P`7]*\OK6&QPXI^\D%%%%6.5['XA_Y%W4/ M^N#_`,J\W60VV%NN,8B4?H*GID/ M^HC_`-T?RI]*!ED M42#VVD$_IFG'2UZMX+<-X6M1 M_=+C_P`?)_K43V.G"OWF;]%%%9'<%%%%`!1110`4444`%%%%`'ALO^N?_>-, MI\O^N?\`WC3*Z7N>3+=A1112$%%%%`!1110`5[!X:_Y%NP_ZY"O'Z]?\,$-X M:L".GE8_4UG4.K"[LUJ***S.T****`"BBB@`KSWXB$?VA9#N(C_.O0J\Y^(7 M_(9MO^O_\AFY_Z]S_ M`.A+7HU><_#W_D,W/_7N?_0EKT:LJFYZ.'_AH****@V.-^(5V8]/M+0'_6R% MS]%'^)_2O/*ZWX@REM<@C[);@_B6/_UJY*MH['G5W>HPHHHJC$****`"BBB@ M`J6VMY;NYBMX5W22,%4>YJ*NO^']B)M4GO&&1;IA?9FSS^0/YTF[*Y<(\TDC MLM"T.WT.R$48#3-@RRXY8_X>@K4HHK`]-))604444#"BBB@#B/B*Q^SZ>N>" MSG]!_C7`UWOQ&_U.G?[TG_LM<%6\?A1Y^(_B!1113,`HHHH`****`"MSP>H; MQ59`^KG\D:L.M_P6`?%5J3V#D?\`?!I/8NDKS1ZM1116!Z@4444`%%%%`!11 M10`4444`;5Z5\003H$)':Y4G_OEJ\UK:&QY^)^,*** M*HP"BBB@`HHHH`*W_!8!\56I/8.1_P!\&L"MSPA*(O%-D2>&++^:D#]<4GL7 M2^-'K-%%%8'J!1110`4444`9OB'_`)%W4/\`K@_\J\.5K#8XL5N@HHHJSE"BBB@`HHHH`****`/=:***YSUPHHHH`*CN(5N;:6! M_N2(4;Z$8J2B@#PV6)X)GBD&'1BK#T(X-,K?\967V/Q'.0,).!,OX]?U!K`K M=.YY4X\LF@HHHIDA1110`4444`%7=)U!M+U6WO%!/EME@.ZG@C\LU2HH&G9W M1[E%+'/"DT3!HW4,K#H0:?7`^"?$2P[=)NW"H3_H[GH">JGZ]O\`]5=]6#5F M>G":G&Z"BBBD6%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4R;_ M`%$G^Z?Y4^D(!!!&0>M`'A=%!&#@]:*Z#R`HHHH`****`"BBB@`KTKX?SB30 MI8L\QSGCV(!_QKS6NO\`A_?"'5)[-C@7"97W9<_$+_D,VW_7N/\`T)J]&KS;X@G_`(GT`[?95_\`0FJX;F&(?[MG)T44 M5J>>%%%%`!1110`4444`=;\/6_XGEPN.ML3_`./+7I%>;?#[_D/S_P#7JW_H M25Z364]ST,/_``PHHHJ#<\O\=_\`(R-_UR3^M(!IEY)QEI@I_`?_`%Z\\KO_`(=3`VU] M!GE75^OJ"/Z5,]C?#_Q#MJ***Q/0"BBB@`HHHH`X?XC?ZG3O]Z3_`-EK@J[W MXC?ZG3O]Z3_V6N"K>/PH\_$?Q`HHHIF`4444`%%%%`!71^!T#>)HB?X8W(_+ M']:YRNE\"?\`(R+_`-Q_6O*Z]HUBV-YHUY;@99X6"CWQQ^M>+UK!Z'%BE[ MR844459RA1110`4444`%2VUP]K=0W$?WXG#K]07=X?U$#_GW<_DI->-U[1K*[M#U!>F;:0?^ M.FO%ZUAL<6*W044459RA1110`4444`%%%%`'NM%%%<5[A?P;_'\_6N&HI-)EPJ.#NCW-'25%>-E=&&0RG((IU>.Z7K^HZ0W^BS MGR\Y,3_,A_#M^&*[&P^(%G*`M];R0/W=/G7_`!'ZUDX-';#$0EOH=C16?:Z[ MI5YCR+^!B>BE]K?D>:T`00"#D&IM8V33U04444#"BBJMQJ=A:_\`'Q>V\7L\ M@!H"]BU17.W7C;1+<$).\[#M%&?YG`K`O?B%<."ME9I$.SRMN/Y#`_G5>7^L:AJ;$W=W) M(/[F<*/^`CBJ-6H=S">*?V4=*/$^HZKKEB)Y-EN+F,^3'POWAU]?QKU"O$;) MQ%?6\A)`656)'L:]NJ9JQ>&DY)W"BBBH.D****`"BBB@#Q*_B\C4;F'&/+E= M?R)%5ZVO%EO]F\37JXP'82#WW`$_J36+70>5-6DT%%%%!(4444`%%%%`!4MM M<2VEU%<0MMDB8,I]Q45%`'L6B:U;ZU8K-$P$H`$L6>4/^'H:TZ\0M;NXLIUG MMIGBE7HR'!KJ;/X@W\*A;JVBN,?Q*=A/UZC]*R<'T.Z&)BU[QZ-17&Q_$2S( M_>6,Z\?PL#_A22?$2S`_=6,['T9@O^-+E9K[:'<[.D)`(!(!)P/>O.KOX@W\ MH(M;6&#W8ER/Y#]*J^'M4O+_`,76,MY#_`-]M7E%>J>"2/^$7M^?XW_\`0C43V.G"_&_0Z&BBBLCN"BBB M@`HHHH`*\U^()!U^#!Z6RY_[Z:O2J\R\??\`(Q+_`-<%_F:N&YAB?@.7HHHK M4\\****`"BBB@`HHHH`ZCP#_`,C$W_7!OYBO3:\P\"$CQ(H!QF%P??I7I]93 MW/0PWP!1114&YYU\0XB-5M)NSP;?R8G_`-FKCZ]$^(5L7TRUN0,^5*5/L&'_ M`-B*\[K:+T/.Q"M4844451B%%%%`!1110`5T7@S4ET_7525@L5POEL2>`>H/ MY\?C7.T4FKJQ4)ZT5Q7AOQI$\4=GJC^7(HVK<,?E;_>]#[UV:.LB!T8 M,I&0P.0:Q:L>G":FKH=1112*"BBB@#C/B(!]@LCCGS6_E7GM>B_$-,Z1:OCI M/C/U4_X5YU6L-CS\1\844459@%%%%`!1110`5TO@3_D9%_ZY/_2N:KHO!#E? M$\`_O(X_\=)_I2DM#2C\:/4Z***P/3"BBB@`HHHH`****`"BBB@`KQS7[$Z= MKEW;8P@1_/%>QUQ?C[2C+;1:G$N6A_=R_[I/!_`G]:N#LS#$0YHW70 M\^HHHK4\\****`"BBB@`HHHH`*D@N)K642V\KQ2#HR,5/YBHZ*`-^W\9ZY!P M;H2CTDC!_7K5U/B#JH^];V;?\`8?^S5R=%+E1HJTUU.N/Q"U/'RVMF#[JQ_] MFJO)X[UE\[3;Q_[L?^)-\4K-J$Q4]50[`?J%Q69113 M(N M%%%%`!1110`5Q_CK1#=6JZG`F98!B4#NGK^'\OI784A`92K`$$8(/>FG9W)G M%2C9GA=%=%XK\.MH]X9X%)LIF)3_`&#_`'3_`$_^M7.ULG<\R47%V84444R0 MHHHH`****`"BBB@`HHHH`*DBGF@.8I7C/JC$5'10"=BZNL:H@PNI7B_2=A_6 MAM9U1QAM2O"/0SM_C5*BBP^9]R66YGG_`-=/))_ON3_.HJ**!-M[A1110`44 M44`*"5((ZCFO=`00"#D&O"J]PM6WVD+8QF-3C\*SJ=#LPO4EHHHK,ZPHHHH` M****`.`^(=EMN;2^4<.IB8^XY'\S^5<37K_B33#JNASVZ#,H'F1?[P[?CR/Q MKR"M8/0X,3&T[]PHHHJSG"BBB@`HHHH`****`"BBB@`HHHH`*T_#K^7XCT\X MSF=1^9Q_6LRKFD-LUJP?^[<1GG_>%!4-)(]IHHHKG/5"H;S_`(\;C_KFW\JF MJGJW_(&OO^O>3_T$TTKNP'BU%%%;GD!1110`4444`%%%%`!7J'@4@^&D`(.) M7!]J\OKTOP`0?#\@':X8'_OE:F:T.C#?&=51116)WA1110`4444`%>8>.V)\ M1D$](4`_6O3Z\L\;ON\3S#&-B(.O7C/]:N&YAB?@.=HHHK4\\****`"BBB@` MHHHH`Z'P2Q7Q1`!T9'!_[Y)_I7JE>3^#3CQ79H_`_ MH16D'T.3%0NE(P:***T.,****`"BBB@`HHHH`*N66JW^GG_1+N6(9SM5OE/X M=*IT4#3:U1TL/CK6HOOO!-_OQX_]!Q5D?$+4\?-:V9/LK#_V:N1HIBW9AN%RA_UW3-M&?_`!T5=K*\,R"7PW8,,<1!>/;C^E:M8/<]:.R"BBBD,*** M*`"BBB@"&[M(+ZUDMKF,212##*?\]:\K\0^'+C0[@GF2T<_NY?Z-Z'^=>M5' M-!%KK]/4?K] M:X\@JQ5@00<$'M6J:9P3A*#LQ****9`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!7M&D-OT6P?GYK>,\_[HKQ>O8_#S[_#NGG.?W"#\ABHGL=6 M%W9I4445D=H4444`%%%%`!7F7C31#I^HF]A3_1KEL\?POW'X]?S]*]-JO>V4 M&H6##]*: MW%+9GCM%%%;GDA1110`4444`%%%%`!7H_P`/6SHEROI@0?^.+ M7JU>2^+V+>*KXGU4?DBU=/%6">)[ M`G^^1^8(KUVO'?#K[/$>GG('[]1S[G%>Q5E/<[L+\#"BBBH.D*RO$&C)K>F- M`<+,IWQ.>S?X&M6B@32:LSPZ>"6VG>"9"DJ':RGJ#4=>H>*/"Z:Q&;FV"I?* M.IX$@]#[^A_R/,YX);:=X9XVCE0X96&"#6T97/.JTG!^1'1115&04444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5K^%W\OQ-8-D#,FWGW!' M]:R*O:*_EZY8/V%Q'GZ;A2>Q4':29[/1116!ZH4444`%%%%`!1110`4444`% M%%%`!4%Y9V]_;-;W42RQ-U5OYCT/O4]%`;GG>L^!+BW+3:8WGQ=?*8XHJU-]3FGAHO M6.AXK17HE[\/K.4EK.ZE@/\`=<;U_H?YU@77@76("?)6*X7U1P#^38JU),YI M4)KH(XD1D/HPQ5&;BUNAM%%%`@HHHH M`***4`L<`$GT%`"4582QO)`#':SL#TVQDYJ9-%U5\;=-O"#W\AL?RH'RR[%& MBM=/"^MN>-.F'UP/YFIU\&Z\W_+CM&.\J?XTKHKV<^Q@T5TR>!-:;J+=./XI M/\!4R_#[53C=<68_X&Q/_H-',A^QGV.3HKLE^'=YCYKZ`'V4FI1\.I>^I)_W MZ/\`C2YT5["IV.(HKN_^%"91)X7@4'F-W0_]]$_UKH:RM`T7^PK%[47!G5I#("5VXR`,=3Z5JUE+<[X) MJ*3"BBBD4%%%%`!1110`4444`%9&K>&M-U@%IH?+G/\`RVCX;\?7\:UZ*+B: M35F>8:GX(U.RW/;`7<0_YY\/C_=_PS7-R1O%(8Y$9'7@JPP1^%>YU6N]/L[] M`MW;13`=-Z@D?0]JT4^YS3PR?PNQXG17I=YX!TN?)MGFMF[`-O7\CS^M8=S\ M/M0C)^SW-O,O^UE#^7(_6J4T82P\T$];MR=U@[CUC(;/Y&LZ73KVW M!,UG<1@?WXF'\Q57,W"2W16HHHH)"BBB@`HHHH`**`,G`ZU:BTV_G`,-ER.2HKT6V^'MC&0;F[GF([(`@/\ZW;+P]I-@0;>QB##^-QO;\SG%2Y MHTCAI/?0\PT_P_JFID&VM'\L_P#+1QM3\SU_"O5-'LY=/TBVM)F5I(DVL4Z? MA5ZBHE*YU4J*IA1114FH4444`%%%%`!1110!!>65OJ%J]M=1+)$W4'^8]#7G M6N>"KO3RTUCNNK;T`S(OU`Z_A^5>F44U)HSJ4HSW/"B,'!ZT5[#J7AW3-5RU MS;*)3_RUC^5OS[_CFN4O?AY,I+6-XCCLDPVG\QU_(5HIHY)8::VU.)HK9N?" MNMVI.ZPD<>L6'S^7-9DZE-_J]/NG_`-V%C_2@:3>Q3HKWKD&ZO((AZ("Y_I2YD6J,WT.ZTU_,TNT?&-T*''_``$5:J&SMA9V-O:J MQ80QK&&/?`QG]*FK!GIH*Q_%3^7X8OVQG*!?S(']:V*HZQIPU;2IK$RF(2[? MG"YQA@>GX4UN*2NG8\8HKO?^%I__"N8 M_P#H)M_WY_\`LJV?#WAE=`FFD6[:;S5"D%-N,?B:F4E;1FE*C.,TV;]%%%9' M8%%%%`!1110`5Y!XF??XEOSG/[TC\N*]?KC[[P&E]?W%T=193-(S[?*!QDYQ MUJX-)ZF->#G&R/.J*[W_`(5S'_T$V_[\_P#V5'_"N8_^@FW_`'Y_^RK3FCW. M7ZO4."HKO?\`A7,?_03;_OS_`/94?\*YC_Z";?\`?G_[*CFCW#ZO4."HKO?^ M%QK4HH$TFK,\HU?PEJ6E,SK&;FW'26(=/J.H_E[U@U[K65J'AO2=2 M8O/:()#R9(_E8_7'7\:T4^YRSPJ^RSQ^BNZO/AV>6L;X'T2=?_9A_A6'<^#= M;M^1:B5?6)P?TZU:DF82HS70P:*MS:7J%N"9K&YC`[M$P'\JJ$8.#UIF;36X M4444""BBB@`HHIRQN_W$9N<<#-`#:*M)IM])]RRN6^D3'^E3IH&L/TTR['.. M8B/YT7*Y9=C.HK93PIKDGW=/D'^\RK_,U8C\$ZZY^:U1/]Z5?Z$TKH:I3?0Y MZBNH3P%K#8RULG^](>/R%3#X>ZGCYKJS!]F8_P#LM',BO8U.QR-%=H/AW1@P^HKN/^%QM)01):P.#U#1@YJ+^R=-_Z!]I_WY7_``JY133:`I_V3IO_ M`$#[3_ORO^%.33;&,DQV5LI/]V)1_2K5%%VP(EMH%^[#&/H@J4````8`HHI` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`QXHY/OQJW^\,U`^F:?(VY[&V8^K1*?Z5:HH`H?V)I/_0+ MLO\`P'3_``H_L32?^@79?^`Z?X5?HIW%RKL4/[$TG_H%V7_@.G^%2IIMC&28 M[*V4G^[$H_I5JBB[!)+8:D:1C"(JC_9&*=112&%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`$+VEM)]^WB;ZH#4/]DZ;_`-`^T_[\ MK_A5RBFFUL!3_LG3?^@?:?\`?E?\*E2RM8P`EM"H'3$8&*GHH;;W`15"C"@` M>@%+112`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"FO''(,.BL.GS#-.HH`K/IMC+CS+*W?'3=$I_I3/[)TW_H'VG_?E?\` M"KE%.[`I_P!DZ;_T#[3_`+\K_A4BV%FB[5M(`OH(QBK%%#;>X#%AB3&R)%QT MPH&*?112`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` BHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_V3\_ ` end